In Vitro Diagnostics (IVD) operating environment is changing rapidly and getting more complex to operate in. Regulators and Payers increase policy scrutiny, diagnostic solutions require more, and better clinical evidence and digital diagnostic solutions challenge the status quo. On the other hand, health care systems face significant cost pressure, innovation cycles are getting shorter and solutions more technologically advanced.
This presentation explores how diagnostics health technology assessments play an ever-growing role in this transition. Highlights:
Key trends leading to more Diagnostics HTA's in Europe
5 diagnostics HTA cases on 3 layers (policy, scientific collaboration, countries)
Interesting examples of future trends